Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art

Bibliography

• Edelson R, Berger C, Gasparro F, Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1997;316:297-303
   Google Scholar
• Trautinger F, Knobler R, Willemze R, EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome. Eur J Cancer 2006;42:1014-30
   PubMed Web of Science ®Google Scholar
• Scarisbrick JJ, Taylor P, Holtick U, U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Br J Dermatol 2008;158:659-78
   PubMed Web of Science ®Google Scholar
• Szczepiorkowski ZM, Winters JL, Bandarenko N, Guidelines on the use of therapeutic apheresis in clinical practice–evidence-based approach from the apheresis applications committee of the American Society for Apheresis. J Clin Apher 2010;25:83-177
   PubMed Web of Science ®Google Scholar
• Moor AC, Schmitt IM, Beijersbergen van Henegouwen GM, Treatment with 8-MOP and UVA enhances MHC class I synthesis in RMA cells: preliminary results. J Photochem Photobiol B 1995;29:193-8
   PubMed Web of Science ®Google Scholar
• Ullrich SE. Photoinactivation of T-cell function with psoralen and UVA radiation suppresses the induction of experimental murine graft-versus-host disease across major histocompatibility barriers. J Invest Dermatol 1991;96:303-8
   PubMed Web of Science ®Google Scholar
• Suchin KR, Cassin M, Washko R, Extracorporeal photochemotherapy does not suppress T or B cell responses to novel or recall antigens. J Am Acad Dermatol 1999;41:980-6
   PubMed Web of Science ®Google Scholar
• Scarisbrick JJ, Taylor P, Holtick U, U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Br J Dermatol 2008;158:659-78
   PubMed Web of Science ®Google Scholar
• McKenna KE, Whittaker S, Rhodes LE, Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group. Br J Dermatol 2006;154(1):7-20
   PubMed Web of Science ®Google Scholar
• Gottlieb S, Wolfe JT, Fox FE, Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alpha, a 10 year experience at a single institution. J Am Acad Dermatol 1996;35:946-57
   PubMed Web of Science ®Google Scholar
• Wolff D, Schleuning M, von Harsdorf S, Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2011;17:1-17
   PubMed Web of Science ®Google Scholar
• Yoo EK, Rook AH, Elenitsas R, Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996;108:235-42
   Google Scholar
• Heshmati F, Andreu G. Extracorporeal photochemotherapy: a historical perspective. Transfus Apheresis Sci 2003;28:25-34
   PubMed Web of Science ®Google Scholar
• Rook AH, Suchin KR, Kao DMF, Photopheresis: clinical applications and mechanism of action. J Invest Dermatol Symp Proc 1999;4:85-90
   PubMed Web of Science ®Google Scholar
• Alcindor T, Gorgun G, Miller KB, Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood 2001;98:1622-5
   PubMed Web of Science ®Google Scholar
• Tambur AR, Ortegel JW, Morales A, Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis. Transplant Proc 2000;32:747-8
   PubMed Web of Science ®Google Scholar
• Salskov-Iversen M, Berger CL. Rapid construction of dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading. J Immune Based Ther Vaccines 2005;3:4
   PubMedGoogle Scholar
• Spisek R, Gasova Z, Bartunkova J. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease. Transfusion 2006;46:55-65
   PubMed Web of Science ®Google Scholar
• Berger CL, Xu AL, Hanlon D, Induction of human tumor-loaded dendritic cells. Int J Cancer 2001;91:438-47
   PubMed Web of Science ®Google Scholar
• Girardi M, Heald PW, Wilson LD. The pathogenesis of mycosis fungoides. N Engl J Med 2004;350:1978-88
   PubMed Web of Science ®Google Scholar
• Yoo EK, Rook AH, Elenitsas R, Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma, relevance to mechanism of therapeutic action. J Invest Dermatol 1996;107:235-42
   PubMed Web of Science ®Google Scholar
• Bladon J, Taylor PC. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Br J Haematol 1999;107:707-11
   PubMed Web of Science ®Google Scholar
• Zouboulis CC, Schmuth M, Doepfmer S, Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4 T lymphocytes. Dermatology 1998;196:305-8
   PubMed Web of Science ®Google Scholar
• Di Renzo M, Rubegni P, De Aloe G, Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma. Immunology 1997;92:99-103
   PubMed Web of Science ®Google Scholar
• Vowels BR, Cassin M, Boufal MH, Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes, implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 1992;98:686-92
   PubMed Web of Science ®Google Scholar
• Edelson RL. Photopheresis, a clinically relevant immunobiologic response modifier. Ann NY Acad Sci 1991;636:154-64
   PubMed Web of Science ®Google Scholar
• Coghill JM, Sarantopoulos S, Moran TP, Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. Blood 2011;177:3268-76
   Google Scholar
• Paczesny S, Hanauer D, Sun Y, Reddy P. New perspectives on the biology of GVHD. Bone Marrow Transplant 2010;45:1-11
   PubMed Web of Science ®Google Scholar
• Dustin ML. Role of adhesion molecules in activation signaling in T lymphocytes. J Clin Immunol 2001;21:258-63
   PubMed Web of Science ®Google Scholar
• Anderson BE, McNiff JM, Jain D, Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ. Blood 2005;105:2227-34
   PubMed Web of Science ®Google Scholar
• Peritt D. Potential mechanisms of photopheresis in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006;12(Suppl 2):7-12
   PubMedGoogle Scholar
• Gatza E, Rogers CE, Clouthier SG, Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood 2008;112:1515-21
   PubMed Web of Science ®Google Scholar
• Gorgun G, Miller KB, Foss FM. Immunologic mechanism of extracorporeal photochemotherapy in chronic graft versus-host disease. Blood 2002;100:941-7
   PubMed Web of Science ®Google Scholar
• Foss FM, Gorgun G, Miller KB. Extracorporeal photopheresis in chronic graft-versus-host disease. Bone Marrow Transplant 2002;29(9):719-25
   PubMed Web of Science ®Google Scholar
• Gatza E, Rogers CE, Clouthier SG, Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood 2008;112:1515-21
   PubMed Web of Science ®Google Scholar
• Aubin F, Mousson C. Ultraviolet light-induced regulatory (suppressor) T cells: an approach for promoting induction of operational allograft tolerance? Transplantation 2004;77(1 Suppl):29-31
   Web of Science ®Google Scholar
• Di Renzo M, Sbano P, De Aloe G. Extracorporeal photopheresis affects co-stimulatory molecule expression and interleukin-10 production by dendritic cells in graft-versus-host disease patients. Clin Exp Immunol 2008;151:407-13
   PubMed Web of Science ®Google Scholar
• Bladon J, Taylor P. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease. Ther Apher Dial 2008;12:311-18
   PubMed Web of Science ®Google Scholar
• Biagi E, Di Biaso I, Leoni V, Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+ Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007;84:31-9
   PubMed Web of Science ®Google Scholar
• Heshmati F. Mechanisms of action of extracorporeal photochemotherapy. Transfus Apher Sci 2003;29:61-70
   PubMed Web of Science ®Google Scholar
• Geskin L. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma. Skin Therapy Lett 2007;12(5):1-4
   PubMedGoogle Scholar
• Rook AH, Wolfe JT. Role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. J Clin Apher 1994;9:28-30
   PubMed Web of Science ®Google Scholar
• Stevens SR, Baron ED, Masten S, Cooper KD. Circulating CD4+CD7- lymphocyte burden and rapidity of response: predictors of outcome in the treatment of Sezary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis. Arch Dermatol 2002;138:1347-50
   PubMed Web of Science ®Google Scholar
• Lim HW, Edelson RL. Photopheresis for the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995;9:1117-26
   PubMed Web of Science ®Google Scholar
• Fraser-Andrew E, Seed P, Whittaker S, Russel-Jones R. Extracorporeal photopheresis in Sezary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone. Arch Dermatol 1998;134:1001-5
   PubMed Web of Science ®Google Scholar
• Russel-Jones R. Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies. Br J Dermatol 2000;142:16-21
   PubMed Web of Science ®Google Scholar
• Duvic M, Hester JP, Lemak NA. Photopheresis therapy for cutaneous T cell lymphoma. J Am Acad 1996;35:573-9
   PubMed Web of Science ®Google Scholar
• Rook A, Prystowsky MB, Cassin M, Combined therapy for Sezary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy. Arch Dermatol 1991;127:1535-40
   PubMed Web of Science ®Google Scholar
• Jumbou O, N'Guyen JM, Tessier MH, Long-term follow-up in 51 patients with mycosis fungoides and Sezary syndrome treated by interferon-alfa. Br J Dermatol 1999;140:427-31
   PubMed Web of Science ®Google Scholar
• Fimiani M, Rubegni P, De Aloe G, Andreassi L. Role of extracorporeal photochemotherapy alone and in combination with interferon alfa in the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 1999;41:502-3
   PubMed Web of Science ®Google Scholar
• Fritz TM, Kleinhans M, Nestle FO, Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin- 2 in a patient with the Sezary syndrome. Br J Dermatol 1999;140:1144-7
   PubMed Web of Science ®Google Scholar
• Rook AH, Gottlieb SL, Wolfe JT, Pathogenesis of cutaneous T-cell lymphoma, implication for the use of recombinant cytokines and photopheresis. Clin Exp Immunol 1997;107:16-20
   PubMed Web of Science ®Google Scholar
• Rook AH, Wood GS, Yoo EK, Interleukin 12 induces lesion regression and cytotoxic T cell responses in cutaneous T cell lymphomas. Blood 1999;94:902-8
   PubMed Web of Science ®Google Scholar
• Bouwhuis SA, Markovic SN, McEvoy MT, Pittelkow MR. Extracorporeal photopheresis and adjuvant aerosolized granulocyte-macrophage colony-stimulating factor for Sezary syndrome. Mayo Clin Proc 2002;77:197-200
   PubMed Web of Science ®Google Scholar
• Wilson LD, Licata AL, Braverman IM, Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy. Int J Radiat Oncol Biol Phys 1995;32:987-95
   PubMed Web of Science ®Google Scholar
• Wilson LD, Jones GW, Kim D, Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythodermic (T4) mycosis fungoides. J Am Acad Dermatol 2000;43:54-60
   PubMed Web of Science ®Google Scholar
• Siakantaris MP, Tsirigotis P, Stavroyianni N, Management of cutaneous T-Cell lymphoma patients with extracorporeal photopheresis. The Hellenic experience. Transfus Apher Sci 2012;46(2):189-93
   PubMed Web of Science ®Google Scholar
• Child FJ, Mitchell TJ, Whittaker SJ, A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides. Clin Exp Dermatol 2004;29(3):231-6
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, Consensus conference on acute GVHD grading. Bone Marrow Transplant 1994;15:825-8
   Web of Science ®Google Scholar
• Rowlings P, Przepiorka D, Klein J, IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 1997;97:855-64
   PubMed Web of Science ®Google Scholar
• Shulman HM, Sullivan KM, Weiden PL, Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17
   PubMed Web of Science ®Google Scholar
• Mielcarek M, Martin PJ, Leisenring W, Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003;102:756-62
   PubMed Web of Science ®Google Scholar
• Filipovich AH, Weisdorf D, Pavletic S, National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant 2005;11:945-56
   PubMed Web of Science ®Google Scholar
• Vigorito AC, Campregher PV, Storer BE, National Institutes of Health.. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 2009;114:702-8
   PubMed Web of Science ®Google Scholar
• Greinix HT, Loddenkemper C, Pavletic SZ, Diagnosis and staging of chronic graft-versus-host disease in the clinical practice. Biol Blood Marrow Transplant 2011;17:167-75
   PubMed Web of Science ®Google Scholar
• Van Lint MT, Uderzo C, Locasciulli A, Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian group for bone marrow transplantation. Blood 1998;92:2288-93
   PubMed Web of Science ®Google Scholar
• Van Lint MT, Milone G, Leotta S, Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin. Blood 2006;107:4177-82
   PubMed Web of Science ®Google Scholar
• Martin PJ, Shoch G, Fisher L, A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. Blood 1991;62:626-31
   Google Scholar
• Bacigalupo A, Palandri F. Management of acute graft-versus host disease (GVHD). Hematol J 2004;5:189-96
   PubMedGoogle Scholar
• Rossetti F, Dall'Amico R, Provetti G, Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transplant 1996;18(Suppl 2):175-81
   PubMedGoogle Scholar
• Messina C, Locatelli F, Lanino E, Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003;122:118-27
   PubMed Web of Science ®Google Scholar
• Kanold J, Paillard C, Halle P, Extracorporeal photochemotherapy for graft versus host disease in pediatric patients. Transfus Apher Sci 2003;28:71-80
   PubMed Web of Science ®Google Scholar
• Greinix HT, Volc-Platzer B, Rabitsh W, Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998;92:3098-104
   PubMed Web of Science ®Google Scholar
• Greinix HT, Knobler RM, Worel N, The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica 2006;91:405-8
   PubMed Web of Science ®Google Scholar
• Greinix HT, Volc-Platzer B, Kalhs P, Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood 2000;96:2426-31
   PubMed Web of Science ®Google Scholar
• Perfetti P, Carlier P, Strada P, Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD. Bone Marrow Transplant 2008;42:609-17
   PubMed Web of Science ®Google Scholar
• Calore E, Calo A, Tridello G, Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. Bone Marrow Transplant 2008;42:421-5
   PubMed Web of Science ®Google Scholar
• Merlin E, Paillard C, Rochette E, Extracorporeal photochemotherapy as second- or first-line therapy of acute GVHD? Bone Marrow Transplant 2010;45:963-5
   PubMed Web of Science ®Google Scholar
• Wolff D, Gerbitz A, Ayuk F, Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant 2010;16:1611-12
   PubMed Web of Science ®Google Scholar
• Child FJ, Ratnavel R, Watkins P, Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1999;23:881-7
   PubMed Web of Science ®Google Scholar
• Bisaccia E, Palangio M, Gonzalez J, Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy. Bone Marrow Transplant 2003;31:291-4
   PubMed Web of Science ®Google Scholar
• Rubegni P, Cuccia A, Sbano P, Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease. Br J Haematol 2005;130:271-5
   PubMed Web of Science ®Google Scholar
• Apisarnthanarax N, Donato M, Korbling M, Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant 2003;31:459-65
   PubMed Web of Science ®Google Scholar
• Dall'Amico R, Rossetti F, Zulian F, Photopheresis in pediatric patients with drug-resistant chronic graft-versus-host disease. Br J Haematol 1997;97:848-54
   PubMed Web of Science ®Google Scholar
• Ilhan O, Arat M, Arslan O, Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease. Transfus Apher Sci 2004;30:185-7
   PubMed Web of Science ®Google Scholar
• Couriel DR, Hosing C, Saliba R, Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006;107:3074-80
   PubMed Web of Science ®Google Scholar
• Foss FM, DiVenuti GM, Chin K, Prospective study of extracorporeal photopheresis in steroid-refractory or steroid resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 2005;35:1187-93
   PubMed Web of Science ®Google Scholar
• Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood 2002;100:941-7
   PubMed Web of Science ®Google Scholar
• Greinix HT, Socie G, Bacigalupo A, Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplant 2006;38:265-73
   PubMed Web of Science ®Google Scholar
• Kanold J, Messina C, Halle P, Update on extracorporeal photochemotherapy for graft-versus-host disease treatment. Bone Marrow Transplant 2005;35(Suppl 1):69-71
   Google Scholar
• Seaton ED, Szydlo RM, Kanfer E, Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood 2003;102:1217-23
   PubMed Web of Science ®Google Scholar
• Gatza E, Rogers CE, Clouthier SG, Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood 2008;112:1515-21
   PubMed Web of Science ®Google Scholar
• Perseghin P, Galimberti S, Balduzzi A, Extracorporeal photochemotherapy for the treatment of chronic graft versus-host disease: trend for a possible cell dose-related effect? Ther Apher Dial 2007;11:85-93
   PubMed Web of Science ®Google Scholar
• Salvaneschi L, Perotti C, Zecca M, Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion 2001;41:1299-305
   PubMed Web of Science ®Google Scholar
• Perotti C, Del Fante C, Tinelli C, Extracorporeal photochemotherapy for graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients. Transfusion 2010;50:1359-69
   PubMed Web of Science ®Google Scholar
• Owsianowski M, Gollnick H, Siegert W, Successful treatment of chronic graft-versus-host disease with extracorporeal photochemotherapy. Bone Marrow Transplant 1994;14:845-8
   PubMed Web of Science ®Google Scholar
• Flowers ME, Apperley JF, van Besien K, A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008;112:2667-74
   PubMed Web of Science ®Google Scholar
• Greinix HT, van Besien K, Elmaagacli AH, Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis—results of a crossover randomized study. Biol Blood Marrow Transplant 2001;17:1775-82
   Google Scholar
• Dignan FL, Greenblatt D, Cox M, Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD. Bone Marrow Transplant 2011; doi https://doi.org/10.1038/bmt.2011.186
   Google Scholar
• Tsirigotis P, Kaloyannidis P, Papalexandri A, Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology. Transfus Apher Sci 2012;46(2):173-80
   PubMed Web of Science ®Google Scholar
• Tsirigotis P, Kapsimalli V, Baltadakis I, Extracorporeal photopheresis in refractory chronic graft-versus-host disease: the influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology. Transfus Apher Sci 2012;46(2):181-8
   PubMed Web of Science ®Google Scholar
• Dall'Amico R, Messina C. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Ther Apher 2002;6:296-304
   PubMedGoogle Scholar
• Kanold J, Merlin E, Halle P, Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature. Transfusion 2007;47:2276-89
   PubMed Web of Science ®Google Scholar
• Perseghin P, Dassi M, Balduzzi A, Mononuclear cell collection in patients undergoing extra-corporeal photo-chemotherapy for acute and chronic graft-vs.-host-disease (GvHD): comparison between COBE Spectra version 4.7 and 6.0 (AutoPBSC). J Clin Apher 2002;17:65-71
   PubMed Web of Science ®Google Scholar
• Perutelli P, Rivabella L, Lanino E, ATP downregulation in mononuclear cells from children with graft-versus-host disease following extracorporeal photochemotherapy. Haematologica 2002;87:335-6
   PubMed Web of Science ®Google Scholar
• Barr ML, Meiser BM, Eisen HJ, Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med 1998;339:1744-51
   PubMed Web of Science ®Google Scholar
• O'Hagan AR, Stillwell PC, Arroliga A, Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation. Chest 1999;115:1459-62
   PubMed Web of Science ®Google Scholar
• Benden C, Speich R, Hofbauer GF, Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience. Transplantation 2008;86:1625-7
   PubMed Web of Science ®Google Scholar
• Morrell MR, Despotis GJ, Lublin DM, The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2010;29:424-31
   PubMed Web of Science ®Google Scholar
• Rook AH, Freundlich B, Nahass GT, Treatment of autoimmune disease with extracorporeal photochemotherapy progressive systemic sclerosis. Yale J Biol Med 1989;62:639-45
   PubMed Web of Science ®Google Scholar
• Rook AH, Freundlich B, Jegasothy BV. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Result of a multicenter trial. Arch Dermatol 1992;128:337-46
   PubMed Web of Science ®Google Scholar
• Di Spaltro FX, Cotrill C, Cahill C, Extracorporeal photochemotherapy in progressive systemic sclerosis. Int J Dermatol 1993;32:417-21
   PubMed Web of Science ®Google Scholar
• Krasagakis K, Dippel E, Ramaker J, Management of severe scleroderma with long term extra-corporeal photopheresis. Dermatology 1998;196:309-15
   PubMed Web of Science ®Google Scholar
• Knobler R, French LE, Kim Y, A randomized, double-blind, placebo controlled trial of photopheresis in systemic sclerosis. J Am Acad Dermatol 2006;54:793-9
   PubMed Web of Science ®Google Scholar
• Enonoto DNH, Mekkes JR, Bossuyt PMM, Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis). J Am Acad Dermatol 1999;41:915-22
   PubMed Web of Science ®Google Scholar
• Cribier B, Faradji T, Le Coz C, Extracorporeal photochemotherapy in systemic sclerosis and severe morphea. Dermatology 1995;191:25-31
   PubMed Web of Science ®Google Scholar
• Zic JA, Miller JL, Stricklin GP, King LE Jr. The North American experience with photopheresis. Ther Apher 1999;3:50-62
   PubMedGoogle Scholar
• Rook AH, Jegasothy BV, Heal P, Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. Ann Intern Med 1990;112:303-5
   PubMed Web of Science ®Google Scholar
• Liang G, Nahass G, Kerdel FA. Pemphigus vulgaris treated with photopheresis. J Am Acad Dermatol 1992;26:779-80
   PubMed Web of Science ®Google Scholar
• Gollnick HPM, Owsianowski M, Taube KM. Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photopheresis. J Am Acad Dermatol 1993;28:122-4
   PubMed Web of Science ®Google Scholar
• Wollina U, Lange D, Looks A. Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases. Dermatology 1999;198:140-4
   PubMed Web of Science ®Google Scholar
• Prinz B, Nachbar F, Plewig G. Treatment of severe atopic dermatitis with extracorporeal photopheresis. Arch Dermatol Res 1994;287:48-52
   PubMed Web of Science ®Google Scholar
• Prinz B, Michelsen S, Pfeiffer C, Plewig G. Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis. J Am Acad Dermatol 1999;40:577-82
   PubMed Web of Science ®Google Scholar
• Radenhausen M, von Kobylezki G, Hoxtermann S, Activation markers in severe atopic dermatitis following extracorporeal photochemotherapy. Acta Dermatol Venereol 2003;83:49-79
   PubMed Web of Science ®Google Scholar
• Ritcher HI, Billmann-Eberwein C, Grewe M, Successful monotherapy of severe and intractable atopic dermatitis by photopheresis. J Am Acad Dermatol 1998;38:585-8
   PubMed Web of Science ®Google Scholar
• Mohla G, Horvath N, Stevens S. Quality of life improvement in a patient with severe atopic dermatitis treated with photopheresis. J Am Acad Dermatol 1999;40:780-2
   PubMed Web of Science ®Google Scholar
• Knobler RM, Graninger W, Lindmaier A, Extracorpreal photochemotherapy for the treatment of SLE: a pilot study. Arthritis Rheum 1992;35:319-24
   PubMed Web of Science ®Google Scholar
• Malawsta S, Trock D, Edelson R. Treatment of rheumatoid arthritis by extracorporeal photochemotherapy: a pilot study. Arthritis Rheum 1991;34:646-54
   PubMed Web of Science ®Google Scholar
• Miller J, Stricklin G, Fine J, Remission of severe epidermolysis bullosa acquisita by extracorporeal photochemotherapy. Br J Dermatol 1995;133:467-71
   PubMed Web of Science ®Google Scholar
• Gordon K, Chan L, Woodley D. Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy. Br J Dermatol 1997;136:415-20
   PubMed Web of Science ®Google Scholar
• Ludvigsson J, Samuelsson U, Ernerudh J, Photopheresis at onset of type 1 diabetes, a randomised, double blind, placebo controlled trial. Arch Dis Child 2001;85:149-54
   PubMed Web of Science ®Google Scholar
• O'Brien CB, Henzel BS, Moonka DK, Extracorporeal photopheresis alone and with interferon-alpha 2a in chronic hepatitis C patients who failed previous interferon therapy. Dig Dis Sci 1999;44:1020-6
   PubMed Web of Science ®Google Scholar
• Reinisch W, Nahavandi H, Santella R, Extracorporeal photochemotherapy in patients with steroid dependent Crohn's disease, a prospective pilot study. Aliment Pharmacol Ther 2001;15:1313-22
   PubMed Web of Science ®Google Scholar
• Abreu MT, von Tirpitz C, Hardi R, Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study. Inflamm Bowel Dis 2009;15:829-36
   PubMed Web of Science ®Google Scholar